Table 1.
Characteristics of patients with SLE by disease activity status
| SLE (n = 96) | Healthy subject (n = 13) | p value | |
|---|---|---|---|
| Age (years) | 50.7 (43.9, 58.8) | 40.0 (31.5, 48.5) | 0.012 |
| Gender (female) | 95 (99.0%) | 12 (92.3%) | 0.626 |
| Ethnicity | 1.000 | ||
| Caucasian | 74 (77.1%) | 13 (100%) | |
| Black Caribbean | 6 (6.3%) | ||
| Black African | 3 (3.1%) | ||
| Indian | 2 (2.1%) | ||
| Pakistani | 3 (3.1%) | ||
| Chinese | 1 (1.0%) | ||
| Other | 3 (3.1%) | ||
| Disease duration (years) | 11.7 (6.84, 21.4) | – | – |
| ≥ 4 ACR criteria | 82 (85.4%) | – | – |
| ACR criteria | – | ||
| Malar rash | 54 (56.3%) | ||
| Discoid rash | 16 (16.7%) | ||
| Photosensitivity | 60 (62.5%) | ||
| Oral ulcers | 54 (56.3%) | ||
| Arthritis | 62 (64.6%) | ||
| Serositis | 32 (33.3%) | ||
| Renal | 26 (27.1%) | ||
| Neurological | 10 (10.4%) | ||
| Haematological | 57 (59.4%) | ||
| Immunological | 48 (50.0%) | ||
| ANA | 82 (85.4%) | ||
| Oral prednisolone use | 41/93 (44.1%) | ||
| Antimalarial use | 66/93 (71.0%) | ||
| Immunosuppressant use | 32/92 (34.8%) |
Results show the number (percentage) or median (IQR) values. The Mann-Whitney U test or Fisher’s exact test was used to compare values in the active and the inactive groups
SLE systemic lupus erythematosus, ACR American College of Rheumatology, ANA antinuclear antibody